PLYGF (PolyPeptide Group AG) Issuance of Debt: $58.2 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

PLYGF PolyPeptide Group AG PLYGF
61 GF Score
Price $43.00
GF Value $40.89
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is PolyPeptide Group AG Issuance of Debt?

PolyPeptide Group AG PLYGF 61 Issuance of Debt is $58.2 Mil as of Dec. 2025. GuruFocus rates PLYGF with a GF Score™ of 61/100 and a GF Value™ of $40.89 (Fairly Valued). The stock has 6 warning signs investors should review.

PolyPeptide Group AG's Issuance of Debt for the six months ended in Dec. 2025 was $35.1 Mil.

PolyPeptide Group AG's Issuance of Debt for the trailing twelve months (TTM) ended in Dec. 2025 was $58.2 Mil.

PolyPeptide Group AG Issuance of Debt Related Terms

PolyPeptide Group AG Issuance of Debt Historical Data

* Premium members only.

The historical data trend for PolyPeptide Group AG's Issuance of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PolyPeptide Group AG Issuance of Debt Chart

PolyPeptide Group AG Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Issuance of Debt
Get a 7-Day Free Trial 28.25 0.00 157.32 0.00 58.55

PolyPeptide Group AG Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Issuance of Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 43.62 0.00 0.00 23.07 35.13
PLYGF
61GF Score
PolyPeptide Group AG PLYGF
Issuance of Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PolyPeptide Group AG Issuance of Debt Calculation

Issuance of Debt represents all the cash inflow from debt, including both long-term debt and short-term debt.

Issuance of Debt for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $58.2 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Issuance of Debt →
What does a Issuance of Debt of $58.2 Mil mean?
PolyPeptide Group AG (PLYGF) has a Issuance of Debt of $58.2 Mil as of Dec. 2025. Issuance of Debt is all the cash inflow from debt, including both long-term debt and short-term debt. View historical data on PolyPeptide Group AG and its competitors.
Is PolyPeptide Group AG's Issuance of Debt too high?
PolyPeptide Group AG's current Issuance of Debt is $58.2 Mil. Overall, PolyPeptide Group AG has a GF Score™ of 61/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does PolyPeptide Group AG's Issuance of Debt compare to ZTS and UTHR?
PolyPeptide Group AG's Issuance of Debt of $58.2 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Issuance of Debt for a Drug Manufacturers company?
A good Issuance of Debt depends on the Drug Manufacturers industry context. However, Issuance of Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Issuance of Debt mean?
A high Issuance of Debt can signal that a stock is expensive relative to its fundamentals. Issuance of Debt is all the cash inflow from debt, including both long-term debt and short-term debt. View historical data on PolyPeptide Group AG and its competitors. PolyPeptide Group AG's current Issuance of Debt is $58.2 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PolyPeptide Group AG stock overvalued right now?
Based on GuruFocus' analysis, PolyPeptide Group AG (PLYGF) is currently considered Fairly Valued. The stock's GF Value™ is $40.89, compared to a current price of $43.00 — trading 5.2% above its estimated fair value. The current Issuance of Debt is $58.2 Mil. PolyPeptide Group AG's overall GF Score™ is 61/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Issuance of Debt calculated?
Issuance of Debt is calculated from a company's financial statements. For PolyPeptide Group AG (PLYGF), the current Issuance of Debt is $58.2 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PolyPeptide Group AG (PLYGF) Overvalued in 2026?

Based on GuruFocus' analysis, PolyPeptide Group AG stock appears to be overvalued. The current stock price of $43.00 is trading 5.2% above its estimated GF Value™ of $40.89. GuruFocus considers PolyPeptide Group AG to be Fairly Valued.

Key valuation signals for PLYGF:

  • Issuance of Debt: $58.2 Mil
  • GF Value™: $40.89 vs. price of $43.00 (5.2% above fair value)
  • GF Score™: 61/100 with 6 warning signs

No single metric tells the full story. See the PLYGF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

PolyPeptide Group AG Business Description

Address Neuhofstrasse 24, Baar, Zug, CHE, 6340
PolyPeptide Group AG is an independent contract development and manufacturing organization (CDMO) focused on peptides and oligonucleotides employed as an active pharmaceutical ingredients (APIs) and used as intermediates in therapeutic products. The company derives majority of its revenue from Europe and Asia.
61GF Score

Get the complete analysis for PLYGF

Issuance of Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$43.00
Price
$40.89
GF Value